Literature DB >> 21498300

Periportal edema in trauma patients: correlation with trauma severity.

Julia Kuhlemann1, Tim Loegters, Singha Roehlen, Falk R Miese, Dirk Blondin, Patric Kröpil, Frank Schellhammer, Axel Scherer, Rotem S Lanzman.   

Abstract

BACKGROUND: Periportal edema (PPE) can be seen in different clinical settings, including in patients following trauma. However, the underlying mechanisms and clinical significance in trauma patients still remain unclear.
PURPOSE: To determine the incidence of PPE in CT scans of trauma patients and to correlate PPE with trauma severity and different patterns of injury.
MATERIAL AND METHODS: We retrospectively analyzed contrast-enhanced spiral CT scans of 127 trauma patients that were referred to our Trauma Center Level I between January 2006 and June 2007. According to the Injury Severity Score (ISS), 70 patients with an ISS < 16 (minor trauma) were assigned to group 1 and 57 patients with an ISS ≥16 (major trauma) to group 2.
RESULTS: The presence of PPE was significantly (p < 0.01) higher in group 2 (22 of 57 patients [38.6%]) than in group 1 (10 of 70 patients [14.3%]). In 29 patients PPE presented with a diffuse pattern and in three patients with a focal pattern, affecting only one liver lobe. In 14 patients PPE was found in absence of abdominal injuries. In addition, PPE was present in five patients with abdominal injuries but without liver injury.
CONCLUSION: PPE is seen significantly more often on abdominal CT scans following major traumas (ISS ≥ 16), but is not necessarily associated with liver injury.

Entities:  

Mesh:

Year:  2011        PMID: 21498300     DOI: 10.1258/ar.2011.100385

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  1 in total

1.  Clinical impact of hyperattenuation of adrenal glands on contrast-enhanced computed tomography of polytraumatised patients.

Authors:  J Schek; S Macht; J Klasen-Sansone; P Heusch; P Kröpil; I Witte; G Antoch; R S Lanzman
Journal:  Eur Radiol       Date:  2013-10-24       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.